Influence of rehabilitation pathway treatment on therapeutic effect and prognosis of patients with non-ST elevation myocardial infarction undergoing PCI
10.3969/j.issn.1008-0074.2017.06.07
- VernacularTitle:康复路径治疗对非ST段抬高性心肌梗死PCI患者的疗效及预后的影响
- Author:
Ying WU
1
;
ting Li ZHANG
;
Li FENG
;
qi Wei LIU
Author Information
1. 中山市人民医院心血管内科
- Keywords:
Rehabilitation;
Myocardial infarction;
Treatment outcome
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2017;26(6):607-610
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore influence of rehabilitation pathway treatment on therapeutic effect and prognosis of patients with non -ST elevation myocardial infarction(NSTEMI)undergoing percutaneous coronary intervention (PCI).Methods:A total of 120 NSTEMI patients undergoing PCI treated in our hospital were selected.They were randomly and equally divided into routine treatment group and rehabilitation pathway group.Therapeutic effect,in-cidence of complications,scores of self -rating anxiety scale(SAS),self-rating depression scale(SDS)and quality of life(QOL)before and after treatment were observed,measured and compared between two groups.Results:Af-ter treatment,total effective rate of rehabilitation pathway group was significantly higher than that of routine treat-ment group(91.7% vs.75.0%,P=0.014).Compared with before treatment,after treatment,there were signifi-cant reductions in scores of SAS and SDS,and significant rise in QOL score in both groups(P=0.001 all);com-pared with routine treatment group after treatment,there were significant reductions in scores of SAS[(50.3 ± 4.8) scores vs.(31.9 ± 4.3)scores]and SDS[(49.6 ± 4.1)scores vs.(32.7 ± 3.8)scores],and significant rise in QOL score[(72.9 ± 5.8)scores vs.(83.6 ± 6.3)scores]in rehabilitation pathway group,P=0.001 all.Incidence rate of complications in rehabilitation pathway group was significantly lower than that of routine treatment group(10.0%vs.26.7%,P=0.018).Conclusion:Rehabilitation pathway treatment can alleviate emotions of anxiety and depres-sion,improve quality of life and therapeutic effect,and reduce incidence of complications in patients with non -ST elevation myocardial infarction undergoing percutaneous coronary intervention.
